Precision Neuroscience
Precision Neuroscience Raises $102M Series C | Brain-Computer Interface
Precision Neuroscience Closes $102M for BCI Development
Precision Neuroscience, developing minimally invasive brain-computer interface technology, has raised $102 million in Series C funding.
The round was led by B Capital with participation from Steadview Capital and Alumni Ventures.
Key Highlights
- Total funding to date: $155 million
- Minimally invasive neural implant approach
- Founded by Neuralink co-founder
Company Overview
Precision Neuroscience is developing minimally invasive brain-computer interface technology to restore function for patients with neurological conditions, competing with Neuralink in the emerging BCI market.
Company Info
Investors (3)
Share
Related Reports
Armadin Raises $255.5M Series B for Autonomous Security
Armadin raised a $255.5 million Series B co-led by Andreessen Horowitz and Accel to scale its agentic security platform and its research, training, and go-to-market efforts.
Homeward Raises $120M Series D for Cash Offer and Bridge Financing
Homeward raised a $120 million Series D led by Saluda Grade, plus $330 million in asset-backed debt, to expand cash offer and bridge financing for real estate agents.
Varda Raises $251M Series D for Space-Based Pharmaceutical Processing
Varda Space Industries raised a $251 million Series D led by Lux Capital and Natural Capital to scale space-based pharmaceutical processing.
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free